Agios Pharmaceuticals
AGIO
$34.34
Share price
-1.89%
Change (1 day)
32.18%
Change (1 year)
Categories
Agios Pharmaceuticals (AGIO) - Total debt
Total debt on the balance sheet as of December 2023 : $71.99 M
According to Agios Pharmaceuticals 's latest financial reports the company's total debt is $71.99 M. A company’s total debt is the sum of all current and non-current debts.
Agios Pharmaceuticals - Total debt on balance sheet (from 2018 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $71.99 M | -15.95% |
| 2022-12-31 | $85.65 M | -11.78% |
| 2021-12-31 | $97.09 M | -7.7% |
| 2020-12-31 | $0.10 B | -7.45% |
| 2019-12-31 | $0.11 B | |
| 2018-12-31 | $N/A |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $70.84 B | 98,301.30% | 🇺🇸 USA |
 Eli Lilly LLY | $26.21 B | 36,306.74% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $22.45 B | 31,094.79% | 🇬🇧 UK |
 Xencor XNCR | $83.43 M | 15.89% | 🇺🇸 USA |
 Exelixis EXEL | $0.20 B | 179.83% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.09 B | 1,423.06% | 🇺🇸 USA |